Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

NCP ready to support Maha govt from outside: Bhujbal
Stating that Nationalist Congress Party (NCP) won"t join the Congress-led government in Maharashtra till the issue of portfolio sharing was resolved, Deputy Chief Minister Chhagan Bhujbal today said his party is ready to extend outside support to the new government till then.

Govt may defer stake sale fund
Facing a fiscal deficit of 6.8 per cent of Gross Domestic Product for the current financial year, the government is likely to delay for a year or two the National Investment Fund (NIF), a move that will enable it to keep disinvestment proceeds in the Consolidated Fund of India (CFI).

News of the day

Aarti drugs up on capex plans
Aarti Drugs closed at Rs 108, higher by Rs 2 or 2.8%, on the BSE.
Public Company

GSK to launch 'promecta' in India by 2009-end

Glaxo SmithKline Pharmaceutical today said it is looking at launching its patented medicine promecta, used in treatment of depleted platelet count, in India by this year-end or early next year. - Aurobindo Pharma receives Swissmedic approval for cefepime for injection - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Sun Pharma invalidates Eli Lilly"s Gemzar patent - Glenmark"s drug fails clinical trials - Aurobindo Pharma to acquire Trident Life Sciences "We are looking to launch our promecta in the Indian market in the fourth quarter of this year or in the first quarter of next year," GSK Vice President South Asia and Managing Director India Hasit Joshipura told reporters on the sidelines of a function here. When asked if the company has got drug regulator DCGI nod for launching the medicine here, he said, "We have applied for the regulatory approval but we haven"t got it yet. But we hope to get it by the end of this year of early next year."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009